Search research articles
Contact Us
Filters
Showing results (181-190 of 189) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 189 results.
The Journal of Clinical Investigation
|
November 7, 2001
Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia
L Z He, T Tolentino, P Grayson, et al.
Blood
|
November 15, 1992
Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent
M Andreeff, R Stone, J Michaeli, et al.
Medical and Pediatric Oncology
|
December 7, 2000
Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro
D C Coffey, M C Kutko, R D Glick, et al.
In Vitro
|
January 1, 1978
Regulation of differentiation in normal and transformed erythroid cells
R A Rifkind, P A Marks, A Bank, et al.
The Journal of Biological Chemistry
|
May 13, 1999
Photoaffinity labeling and mass spectrometry identify ribosomal protein S3 as a potential target for hybrid polar cytodifferentiation agents
Y Webb, X Zhou, L Ngo, et al.
Cancer Research
|
December 15, 1988
Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals
C W Young, M P Fanucchi, T Declan Walsh, et al.
Cancer Research
|
April 28, 2001
The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid
D C Coffey, M C Kutko, R D Glick, et al.
Cancer Research
|
October 4, 2000
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo
L M Butler, D B Agus, H I Scher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2001
Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase
L M Butler, Y Webb, D B Agus, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 189) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 189 results.
The Journal of Clinical Investigation
|
November 7, 2001
Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia
L Z He, T Tolentino, P Grayson, et al.
Blood
|
November 15, 1992
Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent
M Andreeff, R Stone, J Michaeli, et al.
Medical and Pediatric Oncology
|
December 7, 2000
Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro
D C Coffey, M C Kutko, R D Glick, et al.
In Vitro
|
January 1, 1978
Regulation of differentiation in normal and transformed erythroid cells
R A Rifkind, P A Marks, A Bank, et al.
The Journal of Biological Chemistry
|
May 13, 1999
Photoaffinity labeling and mass spectrometry identify ribosomal protein S3 as a potential target for hybrid polar cytodifferentiation agents
Y Webb, X Zhou, L Ngo, et al.
Cancer Research
|
December 15, 1988
Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals
C W Young, M P Fanucchi, T Declan Walsh, et al.
Cancer Research
|
April 28, 2001
The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid
D C Coffey, M C Kutko, R D Glick, et al.
Cancer Research
|
October 4, 2000
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo
L M Butler, D B Agus, H I Scher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2001
Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase
L M Butler, Y Webb, D B Agus, et al.
Page
of 19